Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 25;11(11):e40969. doi: 10.2196/40969

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©Jonas Dubu, Sébastien Boyas, Virginie Roland, Sébastien Landry, Anne-Lise Septans, Magali Balavoine, Hugues Bourgeois, Yoann Pointreau, Fabrice Denis, Christophe Letellier, Katell Le Dû. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 25.11.2022.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.

PMC Copyright notice

Flowchart of the PHARAOM (Physical Activity Program for the Survival of Elderly Patients With Lymphoma) study according to the usual CONSORT (Consolidated Standards of Reporting Trials) flowchart type. R-CHOP: rituximab plus cyclophosphamide, hydroxydaunorubicin (doxorubicin), vincristine, and prednisone.